A Study of Tadalafil in Benign Prostatic Hyperplasia

NCT01183650 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Benign Prostatic Hyperplasia

Interventions

DRUG: Tadalafil

Sponsor

Eli Lilly and Company